IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: Effect enhanced by antiretroviral treatment

AIDS

Volumn 23, Issue 1, 2009, Pages 9-18

  Bento, Cleonice A M ^a,d   Hygino, Joana ^a   Andrade, Regis M ^a   Saramago, Carmen S M ^a   Silva, Renato G ^a   Silva, Agostinho A L ^a   Linhares, Ulisses C ^a   Brindeiro, Rodrigo ^a   Tanuri, Amilcar ^a   Rosenzwajg, Michelle ^b   Klatzmann, David ^b   Andrade, Arnaldo F B ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Sorbonne Université   (France)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

Antiretroviral therapy; Cytokines; HIV; Interleukin 10; Pregnancy; Tumor necrosis factor

Indexed keywords

CD28 ANTIGEN; CD3 ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 1BETA; NEVIRAPINE; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ADULT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; INCUBATION TIME; INFECTION RISK; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE; VERTICAL TRANSMISSION; VIROLOGY; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INTERLEUKIN-10; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; T-LYMPHOCYTE SUBSETS; TH1 CELLS; VIRUS REPLICATION; YOUNG ADULT;

EID: 58149127260     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328317461e     Document Type: Article

References (49)

1. Preble EA, Elias CJ, Winikoff B. Maternal health in the age of AIDS: implications for health services in developing countries. AIDS Care 1994; 6:499-516.
2. Prendergast A, Tudor-Williams G, Jeena P, Burchett S, Coulder P. International perspectives, progress, and future challenges of pediatric HIV infection. Lancet 2007; 370:68-80.
3. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266-271.
4. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006; 212:28-50.
5. Østensen M, Forger F, Villiger PM. Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci 2006; 1069:353-363.
6. Piccini MP, Giudizi MC, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995; 155:128-133.
7. Hanna N, Hanna I, Hieb M, Wagner E, Dougherty J, Balkundi D, et al. Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 2000; 164:5721-5728.
8. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13:217-226.
9. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion. Mol Hum Reprod 2004; 10:347-353.
10. Piccini MP. T cells in normal pregnancy and recurrent pregnancy loss. Reprod Biomed Online 2006; 13:840-844.
11. Wilczynski JR. Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia - the same basic mechanism? Human Immunol 2006; 67:492-511.
12. Belkaid Y, Piccirillo CA, Menmdez S, Shevach EM, Sacks DL. CD4+CD25-F regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:502-507.
13. + regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008; 123:57-65.
14. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004; 40:1062-1071.
15. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2008; 198:7-22.
16. Schuleck RD, Clereci M, Ilolan MJ, Shearer CM. Limiting dilution analysis of interleukin-2-producing T cells responsive to recall and alloantigens in human immunodeficiency virus-infected and uninfected individuals. Eur J Immunol 1993; 23:412-417.
17. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36 (Suppl):1S-15S.
18. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737-742.
19. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunol 2004; 112:38-43.
20. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994; 93:768-775.
21. Kinter AL, Poli G, Fox L, Hardy E, Fauci AS. HIV replication in IL-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol 1995; 154:2448-2459.
22. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-870.
23. Sodora DL, Silvestri C. Immune activation and AIDS pathogenesis. AIDS 2008; 22:439-446.
24. Giorgi JV, Lyles RH, Matud JL, YamashitaTE, MellorsJW, Hultin LE, et al. Multicenter AIDS Cohort Study. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 2002; 29:346-355.
25. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
26. Lederman MM, Kalish LA, Asmuth D, Fiebig E, Mileno M, Busch MP. 'Modeling' relationship among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses. AIDS 2000; 14:951-958.
27. Rosenzweig M, DeMaria MA, Harper DM, Friedrich S, Jain RK, Johnson RP. Increased rates of CD4(R) and CD8(R) T lymphocyte turnover in simian immunodeficiency virus infected macaques. Proc Natl Acad Sci U S A 1998; 95:6388-6393.
28. Han X, Becker K, Degen HJ, Jablonowski H, Strohmeyer G. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Eur J Clin Invest 1996; 26:286-692.
29. + T cells. Blood 2004; 103:4581-4587.
30. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narvaez AB, et al. Immune activation set point during early HIV infection predicts subsequent CD4R T-cell changes independent of viral load. Blood 2004; 104:942-947.
31. McGowan I, Elliott J, Fuerst M, Taing P, Boscardin J, Poles M, et al. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J AIDS 2004; 37:1228-1236.
32. Zachar V, Fink T, Koppelhus U, Ebbesen P. Role of placental cytokines in transcriptional modulation of HIV type 1 in the isolated villous trophoblast. AIDS Res Hum Retroviruses 2002; 18:839-847.
33. Montana LJ, Griffin P, Gordon S. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. J Gen Virol 1994; 75 (Pt 12):3393-3400.
34. Kootstra NA, Van't Wout A, Huisman HG, Niedema F, Schutemaker H. Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages. J Virol 1994; 68:6967-6975.
35. Wang Y, Rice AP. Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis. Virology 2006; 352:485-492.
36. Masood R, Lunardi-Iskandar Y, Moudgil T, Zhang Y, Law RE, Huang CL, et al. IL-10 inhibits HIV replication and is induced by tat. Biochem Biophys Res Commun 1994; 202:374-383.
37. Chang J, Naif HM, Li S, Jozwiak R, Ho-Shon M, Cunningham AL. The inhibition of HIV replication in monocytes by interleukin-10 is kinked to inhibition of cell differentiation. AIDS Res Hum Retroviruses 1996; 12:1227-1235.
38. Weissman D, Poli G, Fauci AS. Interleukin-10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor α and interleukin-6 induction of virus. AIDS Res Hum Retroviruses 1994; 10:1199-1205.
39. Goletti D, Weissman D, Jackson RW, Collins F, Kinter A, Fauci AS. The in vitro of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and anti-inflammatory cytokines. J Infect Dis 1998; 177:1332-1338.
40. Shin DH, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, et al. Genetic restriction of HIV-1 pathogenesis to is promoter alleles of IL-10. Proc Natl Acad Sci U S A 2000; 97:14467-14472.
41. Soderstrom A, Norkrans G, Magnus L. Hepatitis B virus DNA during pregnancy and postpartum: aspects on vertical transmission. Scand J Infect Dis 2003; 35:814-819.
42. Chen J, Chung J, Kao J, Chen DS. Postpartum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother. J Gastroenterol Hepatol 2001; 16:705-709.
43. Pornprosert S, Faye A, Mary JY, Dolcini G, Leechanachai P, Chaouat G, et al. Down modulation pf TNF-alpha mRNA placental expression by AZT used for the prevention of HIV-1 mother-to-child transmission. Placenta 2006; 27:989-995.
44. Martinez-CajasJL, Wainberg MA. Antiretroviral therapy: optimal sequencing of therapy to avoid resistance. Drugs 2008; 68:43-72.
45. Kourtis AP, Schmid CH, Jamieson DJ, Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 2007; 21:607-615.
46. Fiore S, Newell ML, Trabattoni D, Thorne C, Gray L, Savasi V, et al. Antiretroviral therapy-associated modulation of Th1 and Th2 immune response in HIV-infected pregnant women. J Reprod Immunol 2006; 70:143-150.
47. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Lon-lasting recovery in CD4 T cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351:1682-1686.
48. Yangco BG, von Bargen IC, Moorman AC, Holmberg SD. Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. Ann Intern Med 2000; 132:201-205.
49. El Sadr WM, Burman WJ, Grant LB, Matts JP, Hafner R, Crane L, et al. Discontinuation of prophylaxis against Mycobacterium avium complex in HIV-infected patients who have a response to antiretroviral therapy. N Engl J Med 2000; 342:1085-1092.